355 related articles for article (PubMed ID: 17006910)
41. Suppression of adenoviral gene expression in the liver: role of innate vs adaptive immunity and their cell lysis mechanisms.
Minagawa M; Kawamura H; Liu Z; Govindarajan S; Dennert G
Liver Int; 2005 Jun; 25(3):622-32. PubMed ID: 15910500
[TBL] [Abstract][Full Text] [Related]
42. Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation.
Feng D; Mei Y; Wang Y; Zhang B; Wang C; Xu L
Immunol Lett; 2008 Dec; 121(2):127-33. PubMed ID: 18992279
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
44. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
45. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
[TBL] [Abstract][Full Text] [Related]
46. Synergistic effect of radiation and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway.
Chou CH; Chen PJ; Jeng YM; Cheng AL; Huang LR; Cheng JC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1545-52. PubMed ID: 19327909
[TBL] [Abstract][Full Text] [Related]
47. Dual behavior of HCV Core gene in regulation of apoptosis is important in progression of HCC.
Jahan S; Ashfaq UA; Khaliq S; Samreen B; Afzal N
Infect Genet Evol; 2012 Mar; 12(2):236-9. PubMed ID: 22266242
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
[TBL] [Abstract][Full Text] [Related]
49. Malignant transformation of the cultured human hepatocytes induced by hepatitis C virus core protein.
Shan Y; Chen XG; Huang B; Hu AB; Xiao D; Guo ZM
Liver Int; 2005 Feb; 25(1):141-7. PubMed ID: 15698411
[TBL] [Abstract][Full Text] [Related]
50. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice.
Huang W; Dong Z; Wei H; Ding C; Sun R; Tian Z
Liver Int; 2006 Apr; 26(3):339-45. PubMed ID: 16584397
[TBL] [Abstract][Full Text] [Related]
51. RNA interference targeting Fas protects mice from fulminant hepatitis.
Song E; Lee SK; Wang J; Ince N; Ouyang N; Min J; Chen J; Shankar P; Lieberman J
Nat Med; 2003 Mar; 9(3):347-51. PubMed ID: 12579197
[TBL] [Abstract][Full Text] [Related]
52. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis.
Kamegaya Y; Hiasa Y; Zukerberg L; Fowler N; Blackard JT; Lin W; Choe WH; Schmidt EV; Chung RT
Hepatology; 2005 Mar; 41(3):660-7. PubMed ID: 15723444
[TBL] [Abstract][Full Text] [Related]
54. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
55. Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C.
Miyaaki H; Ichikawa T; Nakao K; Takeshita S; Shibata H; Ozawa E; Akiyama M; Miuma S; Eguchi K
Intervirology; 2008; 51(6):394-9. PubMed ID: 19258717
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli.
Tsuchihara K; Hijikata M; Fukuda K; Kuroki T; Yamamoto N; Shimotohno K
Virology; 1999 May; 258(1):100-7. PubMed ID: 10329572
[TBL] [Abstract][Full Text] [Related]
57. Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.
Mair M; Zollner G; Schneller D; Musteanu M; Fickert P; Gumhold J; Schuster C; Fuchsbichler A; Bilban M; Tauber S; Esterbauer H; Kenner L; Poli V; Blaas L; Kornfeld JW; Casanova E; Mikulits W; Trauner M; Eferl R
Gastroenterology; 2010 Jun; 138(7):2499-508. PubMed ID: 20193684
[TBL] [Abstract][Full Text] [Related]
58. The activation and differential signalling of the growth hormone receptor induced by pGH or anti-idiotypic monoclonal antibodies in primary rat hepatocytes.
Li W; Lan H; Liu H; Fu Z; Yang Y; Han W; Guo F; Liu Y; Zhang H; Liu J; Zheng X
Mol Cell Endocrinol; 2013 Aug; 376(1-2):51-9. PubMed ID: 23769824
[TBL] [Abstract][Full Text] [Related]
59. Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.
Rubbia-Brandt L; Taylor S; Gindre P; Quadri R; Abid K; Spahr L; Negro F
J Pathol; 2002 Aug; 197(5):617-23. PubMed ID: 12210081
[TBL] [Abstract][Full Text] [Related]
60. The liver stage of Plasmodium berghei inhibits host cell apoptosis.
van de Sand C; Horstmann S; Schmidt A; Sturm A; Bolte S; Krueger A; Lütgehetmann M; Pollok JM; Libert C; Heussler VT
Mol Microbiol; 2005 Nov; 58(3):731-42. PubMed ID: 16238623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
